|
|
| AEZS-126 / AEterna Zentaris (0 Trials) |
|
| AEZS-129 / AEterna Zentaris (0 Trials) |
|
| AEZS-131 / AEterna Zentaris (0 Trials) |
|
| AEZS-132 / AEterna Zentaris (0 Trials) |
|
| AEZS-134 / AEterna Zentaris (0 Trials) |
|
| AEZS-140 / AEterna Zentaris (0 Trials) |
|
| AF-05 / Shanghai Inst. of Materia Medica, Beijing Collab Pharma (0 Trials) |
|
| AF-220 / Merck (MSD) (0 Trials) |
|
| AF-221 / Merck (MSD) (0 Trials) |
|
| AF106 / Afimmune (0 Trials) |
|
| AFA-101 / AfaSci (0 Trials) |
|
| AFA-102 / AfaSci (0 Trials) |
|
| AFA-2000 / AfaSci (0 Trials) |
|
| afabicin IV (Debio 1450 IV) / Debiopharm (1 Trials) |
|
| afabicin oral (Debio 1450) / Debiopharm (1 Trials) |
|
| afacifenacin fumarate (SMP-986) / Sumitomo Dainippon, Nippon Shinyaku (0 Trials) |
|
| Afala / Materia Medica (0 Trials) |
|
| afamitresgene autoleucel (ADP-A2M4) / Adaptimmune (2 Trials) |
|
| afasevikumab (NI 1401) / Roche (1 Trials) |
|
| AFC-5128 / (0 Trials) |
|
| Afdura (alfuzosin BP + dutasteride) / Sun Pharma (0 Trials) |
|
| Affecizx (hPV19) / Stainwei Biotech (1 Trials) |
|
| affinity-tuned bi-specific CAR-T / AffyImmune Therap (0 Trials) |
|
| Affitope AT04A + adjuvant / AFFiRiS (0 Trials) |
|
| Affitope AD02 / AFFiRiS (0 Trials) |
|
| Affitope AD04 / AFFiRiS (0 Trials) |
|
| Affitope AT06A + adjuvant / AFFiRiS (0 Trials) |
|
| aficamten (CK-274) / Cytokinetics (3 Trials) |
|
| afimetoran (BMS-986256) / BMS (3 Trials) |
|
| afimoxifene / Besins Healthcare (3 Trials) |
|
| afizagabar (S44819) / Servier (0 Trials) |
|
| aflibercept sustained release (OTX-IVT) / Ocular Therap (0 Trials) |
|
| AFM 19 / Affimed (0 Trials) |
|
| AFM11 / Affimed (0 Trials) |
|
| AFM12 / Affimed (0 Trials) |
|
| AFM13 / Affimed (2 Trials) |
|
| AFM15 TandAb / Affimed (0 Trials) |
|
| AFM21 / Affimed (0 Trials) |
|
| AFM22 / Affimed (0 Trials) |
|
| AFM24 / Affimed (3 Trials) |
|
| AFM28 / Affimed (0 Trials) |
|
| Afrezza (recombinant human insulin inhalation) / MannKind (7 Trials) |
|
| afuresertib (LAE002) / Laekna Therap (5 Trials) |
|
| AFX 001 series / Aphoenix (0 Trials) |
|
| AFX 300 series for inflammatory bowel disease / Aphoenix (0 Trials) |
|
| AFX-1251 / Afecta Pharma (0 Trials) |
|
| AG PD 001 / American Gene Technologies (0 Trials) |
|
| AG-0029 / Angita Pharma (0 Trials) |
|
| AG-024322 / Pfizer (0 Trials) |
|
| AG-028262 / Pfizer (0 Trials) |
|
| AG-1296 / Friedrich-Schiller University of Jena, Wuhan University, Zhejiang University (0 Trials) |
|
| AG-270 / Servier (1 Trials) |
|
| AG-636 / Dr. Reddy’s, Agios Pharma (0 Trials) |
|
| AG-67650 / Allgenesis Biotherap (0 Trials) |
|
| AG-73305 / Allgenesis Biotherap (0 Trials) |
|
| AG-946 / Agios Pharma (1 Trials) |
|
| AG01 / A&G Pharma (0 Trials) |
|
| AG011 / Precigen (0 Trials) |
|
| AG014 / Precigen (0 Trials) |
|
| AG015 / Intrexon (0 Trials) |
|
| AG017 / Genten Therap, Precigen (0 Trials) |
|
| AG018 / Precigen, CRS Bio (0 Trials) |
|
| AG019 / Precigen (0 Trials) |
|
| AG0301-COVID19 / Takara, AnGes MG, Osaka University Graduate School of Medicine, Brickell (0 Trials) |
|
| AG0302-COVID19 / Takara, AnGes MG, Osaka University Graduate School of Medicine (2 Trials) |
|
| AG1478 / IDT Australia (0 Trials) |
|
| agalsidase beta biosimilar / Biosidus (0 Trials) |
|
| Agalsidase Beta BS (agalsidase beta biosimilar) / JCR Pharma, Amicus, GSK (0 Trials) |
|
| aganirsen (GS 101) / Gene Signal (1 Trials) |
|
| AGAR T cells / Baylor College of Medicine (2 Trials) |
|
| AGC (analgecine) / Vanway (0 Trials) |
|
| AGEN1181 / Agenus (2 Trials) |
|
| AGEN1223 / Gilead, Agenus (1 Trials) |
|
| AGEN1327 / Agenus (0 Trials) |
|
| AGEN1777 / Agenus, BMS (1 Trials) |
|
| AGEN2373 / Agenus, Gilead (1 Trials) |
|
| agenmestencel-T (MSC_APCETH_101) / Minaris Regenerative Medicine (0 Trials) |
|
| AGENT-797 / Agenus (3 Trials) |
|
| agerafenib (RXDX-105) / Roche, Daiichi Sankyo (1 Trials) |
|
| Aggrastat (tirofiban) / Correvio, Medicure (19 Trials) |
|
| AGI-101H / National Cancer Institute (0 Trials) |
|
| AGI-14100 / Agios Pharma (0 Trials) |
|
| AGI-5198 / Agios Pharma (0 Trials) |
|
| AGI-6780 / Agios Pharma (0 Trials) |
|
| AGIL-RLN / PTC Therapeutics (0 Trials) |
|
| AGK2 / Harvard Medical School, Shanghai Jiao Tong University, Chongqing Medical University (0 Trials) |
|
| AGLE-177 / Aeglea (1 Trials) |
|
| AGM-130 / AnyGen (0 Trials) |
|
| AGN 201781 / Acadia Pharma, AbbVie (0 Trials) |
|
| AGN-151587 / Editas Medicine, AbbVie (1 Trials) |
|
| AGN-151597 / AbbVie (0 Trials) |
|
| AGN-193408 / AbbVie (1 Trials) |
|
| AGN-195263 / AbbVie (0 Trials) |
|
| AGN-223575 / AbbVie (0 Trials) |
|
| AGN-231868 / AbbVie (1 Trials) |
|
| AGN-232411 / AbbVie (0 Trials) |
|
| AGN-241622 / AbbVie (1 Trials) |
|
| AGN-241751 / AbbVie (0 Trials) |
|
| AGN-242071 / AbbVie (0 Trials) |
|
| AGN-242266 / AbbVie (0 Trials) |
|
| AGN-323 / AbbVie (0 Trials) |
|
| AGN205203 / AbbVie (0 Trials) |
|
| agomelatine / Generic mfg. (21 Trials) |
|
| Agrippal (trivalent influenza virus vaccine) / Novartis, CSL Behring (5 Trials) |
|
| Agrylin (anagrelide) / Takeda (1 Trials) |
|
| AGS PSCA / Astellas (0 Trials) |
|
| AGS-004 / CoImmune (0 Trials) |
|
| AGS-009 / Argos Therap (0 Trials) |
|
| AGS-010 / CoImmune (0 Trials) |
|
| AGS-16C3F / Astellas (0 Trials) |
|
| AGS-16M8F / Astellas (0 Trials) |
|
| AGS62P1 / Astellas (0 Trials) |
|
| AGS67E / Astellas (0 Trials) |
|
| AGT-115 / JCR Pharma (0 Trials) |
|
| AGT-190 / JCR Pharma (0 Trials) |
|
| AGT103-T / American Gene Technologies (1 Trials) |
|
| AGTC-402 / AGTC (1 Trials) |
|
| AGTC-501 / AGTC (2 Trials) |
|
| AGT‑110 / JCR Pharma (0 Trials) |
|
| AGT‑160 / JCR Pharma (0 Trials) |
|
| aGvHD therapy / Immplacate (0 Trials) |
|
| AGX 153 / AgonOx (0 Trials) |
|
| AGX323 / Angex Pharma (0 Trials) |
|
| AGX87 / Angex Pharma (0 Trials) |
|
| aHSCT / University of Calgary (0 Trials) |
|
| AHT956 / Novartis (0 Trials) |
|
| AI platform-based Fragile X Syndrome therapeutic / Healx (0 Trials) |
|
| AI-128 / Acusphere (0 Trials) |
|
| AiB-001 / Ai-biopharma (0 Trials) |
|
| AIB301 / AIBIOS (0 Trials) |
|
| AIB501 / AIBIOS (0 Trials) |
|
| AIC-6020 / PHD Biosciences (0 Trials) |
|
| AIC100 / AffyImmune Therap (1 Trials) |
|
| AIC649 / AiCuris (0 Trials) |
|
| Aidixi (disitamab vedotin) / Rongchang Pharma, Seagen (16 Trials) |
|
| Aikening (albuvirtide) / Frontier Biotechnologies (3 Trials) |
|
| AIM-001 / EpicentRx (1 Trials) |
|
| AIM-102 / AIM Therap, NexImmune (0 Trials) |
|
| AIMab7195 / Nestle (0 Trials) |
|
| Aimmugen (freeze-dried inactivated tissue culture hepatitis A vaccine) / Astellas, Meiji Seika, Mitsubishi Tanabe (0 Trials) |
|
| Aimovig (erenumab) / Amgen, Novartis (31 Trials) |
|
| Aimspro (hyperimmune goat serum product) / Daval International (3 Trials) |
|
| AiNEX (bevacizumab biosimilar) / Mycenax (0 Trials) |
|
| AIR 645 / Ionis (0 Trials) |
|
| AIR DNAse (alidornase alfa) / SarcoMed (1 Trials) |
|
| AirDuo Digihaler (salmeterol/fluticasone proprionate) / Teva (1 Trials) |
|
| Aironyl (terbutaline) / Sedico (1 Trials) |
|
| AiRuiKa (camrelizumab) / Jiangsu Hengrui Medicine (329 Trials) |
|
| AiRuiYi (fluzoparib) / Jiangsu Hengrui Medicine (36 Trials) |
|
| AIRZ-FF (glycopyrrolate/formoterol fumarate/fluticasone propionate) / Glenmark (0 Trials) |
|
| AiTan (rivoceranib) / HLB Bio Group (364 Trials) |
|
| AIU2008 / Korea Institute of Radiological and Medical Sciences (0 Trials) |
|
| AIV001 / AiViva BioPharma (3 Trials) |
|
| AJ302 / AnnJi Pharma (0 Trials) |
|
| AJ303 / AnnJi Pharma (0 Trials) |
|
| AJ5012 / Ajou University (0 Trials) |
|
| AJM347 / Eisai (0 Trials) |
|
| Ajovy (fremanezumab) / Otsuka, Teva (12 Trials) |
|
| AK-105 / Asahi Kasei (0 Trials) |
|
| AK0605 / Ark Biosci (0 Trials) |
|
| AK0701 / Ark Biosci (0 Trials) |
|
| AK0705 / Ark Biosci, Scripps Research Institute (0 Trials) |
|
| AK0706 / Ark Biosci (0 Trials) |
|
| AK103 / Akesobio, Taizhou Hanzhong Biopharma (0 Trials) |
|
| AK106 / Asahi Kasei (0 Trials) |
|
| AK106 / Akesobio, Sichuan Kelun Pharma (0 Trials) |
|
| AK109 / Akesobio (3 Trials) |
|
| AK110 / Akesobio (0 Trials) |
|
| AK119 / Akesobio (3 Trials) |
|
| AK120 / Akesobio (3 Trials) |
|
| AK123 / Akesobio (0 Trials) |
|
| AK127 / Akesobio (0 Trials) |
|
| AK1320 MS / Asahi Kasei (1 Trials) |
|
| AK1780 / Eli Lilly (0 Trials) |
|
| AK20 / Obio (0 Trials) |
|
| AK3280 / Ark Biosci (1 Trials) |
|
| Akalux (cetuximab sarotalocan) / Rakuten Medical (3 Trials) |
|
| AKB-6899 / Akebia Therap (0 Trials) |
|
| Akineton (biperiden) / Endo, AbbVie (4 Trials) |
|
| Akis (diclofenac injection) / IBSA Institute Biochemical SA (0 Trials) |
|
| Aklief (trifarotene) / Galderma (3 Trials) |
|
| AKN-028 / SOBI, Akinion Pharma (0 Trials) |
|
| AKO003 / Core One Labs (0 Trials) |
|
| AKO004 / Core One Labs (0 Trials) |
|
| AKP-11 / Akaal Pharma, Boston Pharma (1 Trials) |
|
| AKR-202 / Akron Molecules (0 Trials) |
|
| AKR1C3 Inhibitor 2 / Bayer (0 Trials) |
|
| aKRAS / Oblique Therap (0 Trials) |
|
| AKS-452 / Akston (2 Trials) |
|
| AKT inhibitor / Amgen (0 Trials) |
|
| AKT-SI1 / Samtheo Biopharma (0 Trials) |
|
| Akti-1/2 / University of Rennes 1 (0 Trials) |
|
| Akynzeo IV (fosnetupitant/palonosetron) / Helsinn (0 Trials) |
|
| Akynzeo oral (netupitant/palonesteron FDC) / Helsinn, Roche, Otsuka, Mundipharma (11 Trials) |
|
| AL-002 / Alector, AbbVie (1 Trials) |
|
| AL-034 / J&J (3 Trials) |
|
| AL-8112 / J&J (0 Trials) |
|
| AL002 / Alzamend Neuro (0 Trials) |
|
| AL003 / Alector, AbbVie (0 Trials) |
|
| AL008 / Alector (0 Trials) |
|
|